Antiplatelet Agents Completed Phase 4 Trials for Acetylsalicylic acid (DB00945)

IndicationStatusPhase
DBCOND0071826 (Antiplatelet Agents)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02201771Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft SurgeryTreatment